From: Recent development of surface-enhanced Raman scattering for biosensing
Method | Analytes | SERS substrate | Detection time | Limitation of detection | Physiological environment | Refs. |
---|---|---|---|---|---|---|
Label-SERS | SARS-CoV-2 S protein SARS-CoV S protein MERS-CoV S protein | Anti-spike antibody attached gold nanoparticles | 5 min | 4 pg/mL | N/A | [104] |
SARS-CoV-2 S protein other influenza viruses | DNA aptamers-Au nanopopcorn | 15 min | 10 PFU/mL | SARS-CoV-2 lysis solution | [107] | |
SARS-CoV-2 S protein | Hollow Au NPs, and magnetic beads | 30 min | 2.56 fg/mL | SARS-CoV-2 lysis solution | [108] | |
Breath volatile organic compounds | Ag nanocubes | 5 min | N/A | aerosol | [126] | |
SARS-CoV-2 S protein | Au membranes | N/A | 17 virus/μL | saliva | [127] | |
SARS-CoV-2 S protein HIV-1 P24 | AuNPs films | N/A | 6.07 fg/mL | untreated saliva | [128] | |
Label-free SERS | SARS-CoV-2 S protein SARS-CoV S protein | Au nanoneedle array | 5 min | 80 copies/mL for SARS-CoV-2 | Contaminate Water and simulated urine sample | [6] |
SARS-CoV-2 S protein SARS-CoV, MERS-CoV, et al | AuNP array | 20 min | N/A | throat swabs or sputum | [109] | |
SARS-CoV-2 S protein H1N1 Marburg and Zika virus | field-enhancing metal − insulator antenna | 25 min | 104 copies/mL | viral lysate solutions | [110] | |
SARS-CoV-2 S protein SARS-CoV S protein | SnS2 | N/A | 10–12 M for SARS-CoV-2 S protein | PBS | [120] | |
SARS-CoV-2 RBD SARS-CoV S RBD | ACE2 mimetic peptide-SERS substrate | ≥ 30 min | 300 nM for SARS-CoV-2 RBD | PBS | [129] | |
SARS-CoV-2 S protein SARS-CoV-2 N protein | Au/Cu nanostar | N/A | 8.89 × 10–9 M for SARS-CoV-2 S protein | 70% ethanol | [121] | |
SARS-CoV-2 S protein influenza viruses H1N1 | AgNPs/SiNWs | Few minutes | 9.3 × 10−12 M for SARS-CoV-2 S protein | PBS | [130] | |
SARS-CoV-2 Other influenza viruses | DNA aptamers-AgNPs | 7 min | 5.5 × 104 TCID50/mL for SARS-CoV-2 | Mixture of fetal bovine serum, L-Gln, penicillin / streptomycin | [131] |